Delivery Order SPE2DB22D3301-SPE2DB25FZ0WP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Clobazam 2.5 mg/ml Suspension in a 120 ml quantity, with a ceiling value of $1,167.84. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a $1,330.65 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 2.5 mg/ml clobazam suspension in a 120 ml bottle. The delivery order has an ultimate completion date of July 7, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Clobazam 2.5 mg/ml suspension in a 120ml unit at a firm fixed price of $1,909.32. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 20, 2025. This pharmaceutical supply falls under AmerisourceBergen's broader engagement with the federal government as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded a $5,030.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $1,117.01 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a prescription pharmaceutical product, clobazam 2.5 mg/ml suspension. This contract is a task order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. The IDC enables DLA to efficiently procure a comprehensive...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $4,667.79 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,164,829 units of the medication Clobazam 10 mg tablets. The contract has an ultimate completion date of July 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and AmerisourceBergen, valued at up to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,286.28 firm fixed-price contract is for the supply of Clobazam 2.5 mg/ml suspension in 120 ml bottles. The contract has a completion date of December 14, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,321.96 firm fixed-price delivery order is for the supply of Clobazam 2.5 mg/mL suspension in 120 mL bottles. The contract has an ultimate completion date of July 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,223.72 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count) on September 10, 2025, with completion targeted for September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0WPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,326.69 to AmerisourceBergen Drug Corp for the supply of Clobazam 2.5 mg/mL suspension (120 mL), with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard through a flexible procurement mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/12/25 |